Microfluidic-Based Multi-Organ Platforms for Drug Discovery
AbstractDevelopment of predictive multi-organ models before implementing costly clinical trials is central for screening the toxicity, efficacy, and side effects of new therapeutic agents. Despite significant efforts that have been recently made to develop biomimetic in vitro tissue models, the clinical application of such platforms is still far from reality. Recent advances in physiologically-based pharmacokinetic and pharmacodynamic (PBPK-PD) modeling, micro- and nanotechnology, and in silico modeling have enabled single- and multi-organ platforms for investigation of new chemical agents and tissue-tissue interactions. This review provides an overview of the principles of designing microfluidic-based organ-on-chip models for drug testing and highlights current state-of-the-art in developing predictive multi-organ models for studying the cross-talk of interconnected organs. We further discuss the challenges associated with establishing a predictive body-on-chip (BOC) model such as the scaling, cell types, the common medium, and principles of the study design for characterizing the interaction of drugs with multiple targets. View Full-Text
Share & Cite This Article
Rezaei Kolahchi, A.; Khadem Mohtaram, N.; Pezeshgi Modarres, H.; Mohammadi, M.H.; Geraili, A.; Jafari, P.; Akbari, M.; Sanati-Nezhad, A. Microfluidic-Based Multi-Organ Platforms for Drug Discovery. Micromachines 2016, 7, 162.
Rezaei Kolahchi A, Khadem Mohtaram N, Pezeshgi Modarres H, Mohammadi MH, Geraili A, Jafari P, Akbari M, Sanati-Nezhad A. Microfluidic-Based Multi-Organ Platforms for Drug Discovery. Micromachines. 2016; 7(9):162.Chicago/Turabian Style
Rezaei Kolahchi, Ahmad; Khadem Mohtaram, Nima; Pezeshgi Modarres, Hassan; Mohammadi, Mohammad H.; Geraili, Armin; Jafari, Parya; Akbari, Mohsen; Sanati-Nezhad, Amir. 2016. "Microfluidic-Based Multi-Organ Platforms for Drug Discovery." Micromachines 7, no. 9: 162.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.